Remedy Taking a hit why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Remedy Taking a hit why?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jonathan M. Traxler who started this subject	7/26/2000 1:00:23 PM
From: Thomas DeGagne	of 763

Banc of America Securities and Chase Hambrecht & Quist both downgraded e-commerce product provider Remedy Corp. (NASDAQ: RMDY) Wednesday. -- BoA noted Remedy reported disappointing 2Q00, sales force turnover problems and some new products not gaining expected traction. -- Lowered estimates slightly and price target to $65. Remedy was down 19-15/64 at 22-7/8 on Wednesday morning. -- BoA lowered rating to buy from strong buy. -- Chase cut Remedy from buy to market perform. No details.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next